Stock trading platform Webull Corp saw shares fall in premarket trading today after a big spike during its first week as a ...

Plus: A $3 million prize for scientists working with the Large Hadron Collider, why we’re one step closer to a holodeck and ...

Sachin Talwalkar highlights the urgent need for healthcare brands to combat misinformation by building trust through transparent, expert-backed, and more.

Genomics Market Liquid Biopsy Liquid biopsy is a non-invasive method for detecting cancer by analyzing blood samples for genetic mutations ...

A U.S. House committee on Tuesday asked 23andMe's co-founder to testify next month as it launched an investigation into the ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

Me has filed for bankruptcy as is seeking buyers. Here's what could happen to the company's DNA database, one of the largest ...

23andMe, therefore, had to convince customers that sending a biological sample would provide benefits and that these would outweigh any risks. At first, the company advertised that it provided ...

Me's bankruptcy heightens the debate on genetic data protection. The court will choose between competing plans for overseeing ...

pointing to a host of risks: Genetic data can be used to further discrimination, enable financial fraud, and develop biological weapons, they say. 23andMe has said it will continue operating until ...

Genetic factors are thought to play a major role in the development of autism – but for decades what they are has proven elusive. Now scientists are starting to uncover clues.

Lipoprotein(a) is well established as a risk factor for cardiovascular disease, but patients rarely get tested for it. Now, an alliance between Novartis and genetic testing specialist 23andMe is ...